To verify whether LIPG is affected by m6A modification, we conducted MeRIP-qPCR assays and found that knockdown of IGF2BP1 markedly decreased LIPG m6A levels in CRC cells compared with corresponding control cells (Fig. 5F). The gene discussed is LIPG; the disease is colorectal carcinoma.